menu
svg0-svg
CONNECT WITH THE STUDY TEAM
Refer Patients
Refer-Patients

Because research options for IC/BPS are rare, your patients who continue to suffer from pain associated with IC/BPS may be interested in joining a phase 2 clinical study that will investigate the safety and efficacy of a new, potential pain management option.

The study will evaluate IW-3300, a novel, rectally administered foam designed to target the inhibition of pain receptors in the colon and modify pain relief in the bladder. Based upon phase 1 study data, IW-3300 appears to be well tolerated.

Patients in the study will receive…

  • The investigational drug (approx. 67%) or placebo (approx. 33%)
  • Close study-related care and monitoring
  • Compensation for travel and expenses related to study participation, if needed

 

If you have patients you believe would be interested in this study, please fill out the form below.

We will use the information you provide on this form to subscribe you to BIO Notifier – a clinical research opportunity notification service - to receive future opportunity alerts that match your medical expertise and interests.

You may unsubscribe at any time.

Ironwood-Logo

Copyright © 2022 Ironwood. All rights reserved